Adagio Medical Inc.
(ADGM)
undefined
undefined%
At close: undefined
1.16
3.57%
Pre-market Jan 08, 2025, 06:12 AM EST
Company Description
No Company description available at the moment.
Adagio Medical Inc.
| Country | n/a |
| IPO Date | Jul 23, 2024 |
| Industry | n/a |
| Sector | n/a |
| Employees | 87 |
| CEO | Olav B. Bergheim |
Contact Details
Address: No Address available No city data available, | |
| Website | n/a |
Stock Details
| Ticker Symbol | ADGM |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0002006986 |
| CUSIP Number | n/a |
| ISIN Number | US00534B1008 |
| Employer ID | 00-0000000 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Olav B. Bergheim | Chairman & Chief Executive Officer |
| Hakon Bergheim | Chief Operating Officer |
| John T. Dahldorf | Chief Financial Officer |
| Dr. Alex Babkin Ph.D. | Chief Technical Officer |
| Ilya Grigorov | Vice President of Global Marketing & Product Management |
| Nabil Jubran | Chief Compliance Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 06, 2025 | 424B3 | Filing |
| Jan 06, 2025 | 424B3 | Filing |
| Jan 06, 2025 | 8-K | Current Report |
| Dec 23, 2024 | 424B3 | Filing |
| Dec 23, 2024 | 424B3 | Filing |
| Dec 23, 2024 | 8-K | Current Report |
| Dec 20, 2024 | 3 | Filing |
| Dec 16, 2024 | 424B3 | Filing |
| Dec 16, 2024 | 424B3 | Filing |
| Dec 16, 2024 | 8-K | Current Report |